| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/01/2009 | US20090004722 bovine parainfluenza virus (bPIV) cDNA or RNA which may be used to express heterologous gene products; tumor antigens; cancer |
| 01/01/2009 | US20090004721 genetic construct encoding dengue viral genome comprising full-length genome of dengue virus wherein construct is modified at 13-amino acid encoding region just proximal to pr-M cleavage site so that it is devoid of negatively-charged amino acids and contains additional positively-charged amino acids |
| 01/01/2009 | US20090004216 inducing an immunological response in an animal by administering to the animal an attenuated CSFV pestivirus, wherein the RNase activity of glycoprotein ERNS of the CSFV pestivirus is inactivated by a deletion of the second histidine of the conserved ERNS sequence RHEWNKHGWCNW |
| 01/01/2009 | US20090004146 Humanised Baculovirus |
| 12/31/2008 | WO2009002981A1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use |
| 12/31/2008 | WO2009001975A1 Novel hepatitis c virus mutants having enhanced replication and infectivity |
| 12/31/2008 | WO2009000891A2 Linear expression constructs for production of influenza virus particles |
| 12/31/2008 | WO2009000445A1 Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process |
| 12/31/2008 | WO2008135229A3 Formulation of sugar solutions for continuous ultracentrifugation for virus purification |
| 12/31/2008 | EP2009119A1 Compositions for treating cancer using viruses |
| 12/31/2008 | EP2008669A1 Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2007883A2 Purification processes for isolating purified vesicular stomatitis virus from cell culture |
| 12/31/2008 | EP1678193B1 Hepatocellular carcinoma specific promoter and uses thereof |
| 12/31/2008 | EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/31/2008 | EP1305039B1 Stable (fixed) forms of viral l1 capsid proteins, fusion proteins and uses thereof |
| 12/31/2008 | EP1287152B1 Human-bovine chimeric respiratory syncytial virus vaccines |
| 12/31/2008 | EP1268761B1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 12/31/2008 | EP1165127B1 Multivalent dengue virus vaccine |
| 12/31/2008 | EP0989863B1 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 12/31/2008 | CN201171832Y Disposable blood virus inactivation filter |
| 12/31/2008 | CN100447247C Recombinant infectious non-segmented negative strand RNA virus |
| 12/31/2008 | CN100446812C MVA expressing modified HIV envelope, GAG, and pol genes |
| 12/31/2008 | CA2691755A1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use |
| 12/31/2008 | CA2689569A1 Linear expression constructs for production of influenza virus particles |
| 12/31/2008 | CA2688586A1 Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process |
| 12/30/2008 | US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 12/30/2008 | US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization |
| 12/30/2008 | US7470426 Treatment of neoplasms with viruses |
| 12/30/2008 | CA2391591C Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 12/30/2008 | CA2197683C Method for preparing an influenza virus, antigens obtained and applications thereof |
| 12/28/2008 | CA2634144A1 Novel fish pathogen |
| 12/25/2008 | US20080318867 Virulent Phages to Control Listeria Monocytogenes in Foodstuffs and in Food Processing Plants |
| 12/25/2008 | US20080318320 Targeting vector to the urokinase plasminogen activator receptor |
| 12/25/2008 | US20080318301 Methods for Preparing Cells and Viruses |
| 12/25/2008 | US20080318300 Method for Inactivating Viruses With Slightly Acidic Arginine |
| 12/25/2008 | US20080318299 Isolated Human Cell, Method for Obtaining the Same and their Use |
| 12/25/2008 | US20080318298 Uncoupling of DNA insert propagation and expression of protein for phage display |
| 12/25/2008 | US20080318204 Highly-Sensitive Genomic Assays Employing Chimeric Bacteriophage Standards |
| 12/25/2008 | US20080317778 Modified vaccinia ankara virus variant and cultivation method |
| 12/25/2008 | US20080317777 Cdna Construct Of Salmonidae Alphavirus |
| 12/25/2008 | US20080317717 Anti-hepatitis b virus ribozymal nucleic acid |
| 12/25/2008 | US20080317715 Anti-bacterial agents |
| 12/24/2008 | WO2008157596A1 Novel pseudomonas aeruginosa: bacteriophage and uses thereof |
| 12/24/2008 | WO2008157583A1 Influenza b viruses having alterations in the hemaglutinin polypeptide |
| 12/24/2008 | WO2008157530A2 Vaccine design methodology |
| 12/24/2008 | WO2008157136A1 Chimeric sle/dengue type 4 antigenic viruses |
| 12/24/2008 | WO2008156681A2 Adenoviral vectors for influenza virus production |
| 12/24/2008 | WO2008154867A1 Material with immunogenicity |
| 12/24/2008 | WO2008100290A9 Recombinant rhinovirus vectors |
| 12/24/2008 | WO2008080003A3 Generation of oncolytic adenoviruses and uses thereof |
| 12/24/2008 | EP2005183A1 Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody |
| 12/24/2008 | EP1328291B1 Viruses targeted to hypoxic cells and tissues |
| 12/24/2008 | EP1097212B1 Anthrax vaccine |
| 12/24/2008 | CN101331223A Cell display of antibody libraries |
| 12/24/2008 | CA2691091A1 Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 12/24/2008 | CA2690673A1 Methods of treating cell culture media for use in a bioreactor |
| 12/24/2008 | CA2690196A1 Influenza b viruses having alterations in the hemaglutinin polypeptide |
| 12/23/2008 | US7468263 Method for controlling biological function with mechanical vibration and device therefor |
| 12/23/2008 | CA2364499C Means and methods for fibroblast-like or macrophage-like cell transduction |
| 12/23/2008 | CA2139515C Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 12/23/2008 | CA2105300C Process for the development of binding mini-proteins |
| 12/18/2008 | WO2008153572A1 Construction of chimera prrsv, compositions and vaccine preparations |
| 12/18/2008 | WO2008153421A1 Anticancer therapies |
| 12/18/2008 | WO2008153236A1 An attenuated influenza virus and a live vaccine comprising the same |
| 12/18/2008 | WO2008085147A3 Novel plant virus particles and methods of inactivation thereof |
| 12/18/2008 | WO2008076371A3 Method for replicating influenza virus in culture |
| 12/18/2008 | US20080312176 Gene silencing |
| 12/18/2008 | US20080311643 Phenotypes; for the removal of antibiotic-resistant or other undesirable pathogens from medical, veterinary, and animal husbandry applications |
| 12/18/2008 | US20080311576 Replication competent hepatitis C virus and methods of use |
| 12/18/2008 | US20080311154 Cold-adapted equine influenza viruses |
| 12/18/2008 | US20080311153 prepared by mating isolated strains; for prevention of seasonal and sudden outbreaks |
| 12/18/2008 | US20080311150 Novel sequences encoding hepatitis C virus glycoproteins |
| 12/18/2008 | US20080311149 DNA-transfection system for the generation of infectious influenza virus |
| 12/18/2008 | US20080311148 DNA-transfection system for the generation of infectious influenza virus |
| 12/18/2008 | US20080311143 Porcine reproductive respiratory syndrome virus (PRRSV); replicons |
| 12/18/2008 | CA2681454A1 Raccoon poxvirus expressing rabies glycoproteins |
| 12/17/2008 | EP2003200A1 Phage display by novel filamentous bacteriophage |
| 12/17/2008 | EP2001459A2 Methods and compositions for inducing an immune response to hiv and models for testing |
| 12/17/2008 | EP1614426B1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 12/17/2008 | EP1144607B1 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 12/17/2008 | EP0975810B1 Method of pcr testing of pooled blood samples |
| 12/17/2008 | CN101323857A Modified measles virus whole gene cDNA clone and infectious virus preparation |
| 12/17/2008 | CN100443593C Methods for stable transduction of cells with viral vectors |
| 12/16/2008 | US7465794 genetic engineered RNA viruses that express immunology modulators such as cytokines, chemokines, enzymes, cytokine and chemokine antagonist, surface receptors, adhesion molecule or ligands; genetic vaccines |
| 12/16/2008 | US7465583 Comprising adeno-associated virus terminal repeat sequences; intrastrand base-pairing |
| 12/16/2008 | US7465580 vector encoding a derivative of EBNA-1 that is not cytotoxic when expressed efficiently in cells, which supports extrachromosomal replication, maintenance and transcription from extrachromosomal oriP containing vectors but does not substantially activate transcription from host cell genes |
| 12/16/2008 | US7465574 Recombinant RSV virus expression systems and vaccines |
| 12/16/2008 | US7465573 for preventing/treating infectious diseases from donor animals during xenotransplantation |
| 12/16/2008 | US7465456 entirely from cloned cDNA; production of attenuated live influenza A and B virus suitable for vaccines, such as live virus vaccine formulations; increasing growth of a reassortant influenza virus in embryonated eggs |
| 12/16/2008 | CA2449071C Chimaeric phages |
| 12/16/2008 | CA2285667C Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a |
| 12/11/2008 | WO2008150158A1 Novel plant virus designated tomato marchitez virus |
| 12/11/2008 | WO2007022425A3 Influenza recombinant subunit vaccine |
| 12/11/2008 | US20080306061 Aminophenylsulfonamide Derivatives as Hiv Protease Inhibitor |
| 12/11/2008 | US20080305130 Marked Bovine Viral Diarrhea Virus Vaccines |
| 12/11/2008 | US20080305129 Highly Attenuated Pox Virus Strains, Method for the Production Thereof and the Use Thereof as Paramunity Inducers or For Producing Vector Vaccines |
| 12/11/2008 | US20080305119 Modified Bacteriophage Vectors and Uses Thereof |
| 12/11/2008 | US20080305084 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 12/11/2008 | CA2689272A1 Novel plant virus designated tomato marchitez virus |